Ciyive

Ciyive is a biotechnology company dedicated to developing a novel class of therapeutics that target the body's internal circadian clock. Founded by pioneering researchers Ying-Hui Fu and Louis Ptáček from the University of California, San Francisco, the company leverages deep insights into the genetic and molecular mechanisms of sleep and biological rhythms. Ciyive's platform aims to address a wide range of conditions influenced by circadian disruption, including sleep-wake disorders, metabolic diseases, and neurodegenerative pathologies. By modulating core clock proteins, the company seeks to restore healthy physiological rhythms and improve patient outcomes. Ciyive is backed by prominent life science investors, including ARCH Venture Partners.